GeoVax Labs, Inc.

GOVX

GeoVax Labs, Inc.

GOVX

Insider Sentiment (TTM):

Last Purchase:2025-10-17Last Sale:-Shares Purchased (TTM):10,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:322,920Shares Outstanding:2,008,134Institutional Ownership Pct.:16.08%

Earnings Market Reaction:

Filing Date:2026-07-27Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Cash And Cash Equivalents At Carrying Value	3	1	3	5	3	7	6	9	2	1	6	13
Assets Current
Assets Current	4	2	5	7	5	11	8	11	4	3	8	15
Accounts Receivable Net Current	-	-	0	0	1	1	1	1	0	-	0	-
Prepaid Expense And Other Assets Current	1	1	2	2	2	2	2	2	2	2	1	2
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	0	0	1	-	-	-	0	-	-	-	-	-
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	1	1
Assets	5	3	6	7	5	11	8	11	4	3	9	16
Accounts Payable Current	2	1	1	1	2	2	2	2	4	2	3	4
Liabilities Current
Liabilities Current	3	2	2	2	3	3	3	3	6	3	4	7
Notes Payable Current	-	-	-	-	-	-	-	-	0	-	-	-
Accrued Liabilities Current	1	1	1	1	1	1	1	0	2	1	1	3
Operating Lease Liability Current	0	0	0	-	-	-	0	-	-	-	-	-
Operating Lease Liability Noncurrent	0	0	1	-	-	-	0	-	-	-	-	-
Liabilities	3	2	3	-	-	-	3	-	-	-	-	-
Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	162	157	155	151	143	143	134	130	113	110	110	106
Retained Earnings Accumulated Deficit	-161	-156	-151	-146	-140	-135	-129	-121	-115	-110	-104	-97
Stockholders Equity	2	0	4	5	3	8	5	9	-2	0	6	9
Liabilities And Stockholders Equity	5	3	6	7	5	11	8	11	4	3	9	16
Common Stock Par Or Stated Value Per Share	0.001	0.001	0	0.001	0.001	0.001	0	0.001	0.001	0.001	0	0.001
Common Stock Shares Authorized	150	150	150	150	150	150	150	150	150	150	600	600
Shares Outstanding	7	3	2	1	1	1	0	0	0	0	0	0
Common Stock Shares Issued	7	3	2	1	1	1	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	30.95%	-5.56%	-45.95%	-	-	-	-	-	-	-	-	-
2025	2.12%	-4.55%	-22.65%	3.51%	-12.43%	-25.27%	-19.62%	-55.86%	-76.12%	30.47%	28.91%	-7.03%
2024	-5.29%	64.71%	12.94%	157.22%	36.11%	15.00%	-22.46%	-18.77%	-41.23%	-34.65%	-22.44%	-18.90%
2023	-	-	-	2.15%	-7.72%	-10.23%	-24.73%	-34.36%	-48.36%	-23.05%	-41.41%	-33.59%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.54	1.06	2.74	3.57	2.03	3.62	2.55	4.17	0.60	0.87	2.24	2.09
Quick Ratio	1.16	0.55	1.59	2.75	1.43	3.04	1.98	3.50	0.29	0.23	1.83	1.79
Working Capital	1.46M	139.78K	3.38M	4.69M	2.61M	7.68M	4.83M	8.26M	-2.56M	-441.53K	4.37M	7.72M
Leverage & Debt
Debt to Equity	1.64	5.04	0.66	0.37	0.90	0.37	0.62	0.31	-2.77	60.87	0.61	0.78
Interest Coverage TTM	-	-	-	-	-1,776.83	-1,153.98	-1,176.34	-1,145.90	-3,735.44	-	-	-
Debt Ratio	0.62	0.83	0.40	0.27	0.47	0.27	0.38	0.23	1.56	0.98	0.38	0.44
Efficiency & Turnover
Asset Turnover TTM	0.00	0.12	0.34	0.38	1.30	0.79	0.45	0.23	0.02	0.00	0.00	0.00
Days Sales Outstanding TTM	-	-	-	-	24.76	97.76	60.86	64.68	365.00	-	-	-
Receivables Turnover TTM	-	-	-	-	14.74	3.73	6.00	5.64	1.00	-	-	-
Per Share Metrics
Free Cash Flow Per Share TTM	-4.03	-9.50	-22.43	-29.92	-44.58	-52.25	-119.03	-106.42	-226.85	-286.93	-347.64	-312.75
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-	-2,523.43%	-869.34%	-761.63%	-407.34%	-441.15%	-635.83%	-792.63%	-9,059.16%	-	-	-
Net Profit Margin TTM	-	-2,507.27%	-862.34%	-754.69%	-403.80%	-438.17%	-631.98%	-787.08%	-8,951.60%	-	-	-
Growth Metrics
Net Revenue Growth (1Y)	-100.00%	-84.76%	-37.06%	8.52%	1,943.07%	-	-	-	-	-	-100.00%	-100.00%
Net Income Growth (1Y)	-17.66%	-12.78%	-14.11%	4.06%	-7.84%	-11.80%	-3.75%	2.37%	39.33%	77.71%	85.20%	6.16%
EPS Growth (1Y)	-88.92%	-79.23%	-81.41%	-67.15%	-84.76%	-82.54%	-66.28%	-71.71%	-14.26%	31.83%	15.31%	-6.12%
Valuation Metrics
P/E TTM	-0.28	-0.13	-0.19	-0.38	-0.54	-0.52	-0.51	-0.63	-0.30	-0.17	-0.38	-0.57
P/B TTM	3.29	5.61	1.07	1.96	4.71	1.60	2.54	1.82	-3.50	87.22	1.71	1.50
P/S TTM	-	3.25	1.65	2.86	2.17	2.27	3.24	5.00	26.90	-	-	-
Market Cap	5.80M	2.77M	4.10M	9.60M	13.30M	12.67M	12.81M	15.44M	8.09M	4.73M	9.84M	13.64M
Enterprise Value	2.65M	1.50M	1.01M	4.59M	10.21M	5.23M	7.31M	6.84M	6.67M	3.97M	3.39M	956.61K
Calculated Values
Free Cash Flow TTM	-18.38M	-19.07M	-21.50M	-24.28M	-27.39M	-24.98M	-24.70M	-27.26M	-23.05M	-27.17M	-25.27M	-22.14M
Net Debt	-3.14M	-1.27M	-3.09M	-5.01M	-3.09M	-7.44M	-5.51M	-8.59M	-1.42M	-768.86K	-6.45M	-12.69M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-10-17Purchase

Owner: Spencer, John N Jr

Title: -

Shares: 10,000

Price/Share: $0.55

Value: $5,500.00

Shares Owned: 21,402

Relationship: Director

Ownership: Direct

2025-08-07Purchase

Owner: Mckee, Kelly T. Jr.

Title: Chief Medical Officer

Shares: 1,107

Price/Share: $0.67

Value: $741.69

Shares Owned: 3,494

Relationship: Officer

Ownership: Direct

2025-04-10Purchase

Owner: Sharkey, John W.

Title: VP, Business Development

Shares: 6,000

Price/Share: $0.99

Value: $5,940.00

Shares Owned: 6,191

Relationship: Officer

Ownership: Direct

2025-04-10Purchase

Owner: Spencer, John N Jr

Title: -

Shares: 10,000

Price/Share: $0.98

Value: $9,800.00

Shares Owned: 11,402

Relationship: Director

Ownership: Direct

2025-04-01Purchase

Owner: Dodd, David A

Title: President, CEO

Shares: 10,000

Price/Share: $1.08

Value: $10,800.00

Shares Owned: 36,661

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-10-17	Spencer, John N Jr	Director	-	Direct	Purchase	10,000	0.55	$5,500.00	21,402	4
2025-08-07	Mckee, Kelly T. Jr.	Officer	Chief Medical Officer	Direct	Purchase	1,107	0.67	$741.69	3,494	4
2025-04-10	Sharkey, John W.	Officer	VP, Business Development	Direct	Purchase	6,000	0.99	$5,940.00	6,191	4
2025-04-10	Spencer, John N Jr	Director	-	Direct	Purchase	10,000	0.98	$9,800.00	11,402	4
2025-04-01	Dodd, David A	Director,Officer	President, CEO	Direct	Purchase	10,000	1.08	$10,800.00	36,661	4
2025-03-31	Reynolds, Mark	Officer	CFO	Direct	Purchase	6,800	1.08	$7,344.00	14,013	4
2024-08-09	Dodd, David A	Director,Officer	President, CEO	Direct	Purchase	8,000	1.95	$15,600.00	26,661	4
2024-02-22	Dodd, David A	Director,Officer	President, CEO	Direct	Purchase	8,209	2.27	$18,634.43	18,661	4
2024-02-07	Reynolds, Mark	Officer	CFO	Direct	Purchase	2,000	2.77	$5,540.00	7,213	4
2023-12-22	Mckee, Kelly T. Jr.	Officer	Chief Medical Officer	Direct	Purchase	6,944	0.36	$2,499.84	35,782	4
2023-09-25	Mckee, Kelly T. Jr.	Officer	Chief Medical Officer	Direct	Purchase	9,653	0.52	$5,019.56	28,838	4
2023-08-25	Dodd, David A	Director,Officer	President, CEO	Direct	Purchase	35,087	0.57	$19,999.59	148,957	4
2023-08-18	Reynolds, Mark	Officer	CFO	Direct	Purchase	10,000	0.52	$5,200.00	78,184	4
2023-04-24	Dodd, David A	Director,Officer	President, CEO	Direct	Purchase	32,000	0.64	$20,480.00	113,870	4
2023-04-20	Reynolds, Mark	Officer	CFO	Direct	Purchase	8,000	0.63	$5,040.00	68,184	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

16.08%

Inst. Shares: 322,920

Shares Outstanding: 2,008,134

2025-12-31

263.07%

Inst. Shares: 2,521,415

Shares Outstanding: 958,443

2025-09-30

239.43%

Inst. Shares: 1,942,925

Shares Outstanding: 811,488

2025-06-30

89.85%

Inst. Shares: 551,986

Shares Outstanding: 614,369

2025-03-31

245.33%

Inst. Shares: 1,173,125

Shares Outstanding: 478,192

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	322,920	2,008,134	16.08%
2025-12-31	2,521,415	958,443	263.07%
2025-09-30	1,942,925	811,488	239.43%
2025-06-30	551,986	614,369	89.85%
2025-03-31	1,173,125	478,192	245.33%
2024-12-31	289,706	207,482	139.63%
2024-09-30	408,862	256,192	159.59%
2024-06-30	194,363	101,595	191.31%
2024-03-31	240,802	94,682	254.33%
2023-12-31	207,267	72,691	285.13%
2023-09-30	103,495	70,784	146.21%
2023-06-30	104,902	62,516	167.80%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

GeoVax Labs, Inc. (GOVX) — SEC Financial Statements & Analysis

GeoVax Labs, Inc. (GOVX) is a pharmaceutical preparations company, incorporated in DE. GeoVax Labs, Inc. trades on Nasdaq as: GOVX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), GeoVax Labs, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 1.64x, a Price-to-Sales (P/S) ratio of 3.25x (TTM), a Price-to-Book (P/B) ratio of 3.29x (TTM), at a market cap of $5.80M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: 1.64x
P/S TTM: 3.25x
P/B TTM: 3.29x
Market Cap: $5.80M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is GeoVax Labs, Inc. in?

GeoVax Labs, Inc. (GOVX) operates in the Pharmaceutical Preparations industry.

What is GOVX's market cap?

GeoVax Labs, Inc. (GOVX) has a market capitalization of $5.80M as of 2026-06-30.

What exchange does GOVX trade on?

GeoVax Labs, Inc. (GOVX) trades on the Nasdaq.

Where is GeoVax Labs, Inc. incorporated?

GeoVax Labs, Inc. is incorporated in DE.

GeoVax Labs, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

GeoVax Labs, Inc. (GOVX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

GeoVax Labs, Inc. (GOVX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.